Ruscogenin

Ruscogenin is a naturally occurring steroidal sapogenin primarily isolated from the rhizomes of Ruscus aculeatus (Butcher's broom) and the tubers of Ophiopogon japonicus. It is widely recognized for its potent anti-inflammatory, anti-thrombotic, and venotonic pharmacological activities [PubChem CID 119033]. Ruscogenin is not a therapeutic target itself; rather, it is a bioactive ligand that modulates several biological pathways. Its primary mechanisms include the inhibition of the NF-kappaB signaling pathway and the down-regulation of adhesion molecules such as ICAM-1 and VCAM-1 in endothelial cells [PMID: 24508531]. Recent research has also identified ruscogenin as an agonist for the Liver X Receptor alpha (LXRalpha), which contributes to its protective effects against acute lung injury and inflammatory disorders [PMID: 26455314]. In clinical contexts, it is often studied for its potential in treating chronic venous insufficiency and diabetic retinopathy. Because it is a small molecule compound rather than a protein receptor or enzyme, it is classified as a bioactive metabolite rather than a drug target.

Other names

(25R)-Spirost-5-ene-1beta,3beta-diol1beta,3beta-Dihydroxy-25R-spirost-5-eneRuscogenine

Not applicable; Ruscogenin is a bioactive small molecule (ligand) rather than a therapeutic target.